Clinical Trial Update: A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of MK-0517 in healthy subjects. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• MK-0517

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chemotherapy-Induced Nausea and Vomiting, Postoperative Nausea and Vomiting | Phase 1 | Status: COMPLETED | Results posted: 2013-12-12